Daniel Billen
Chairman chez AURINIA PHARMACEUTICALS INC.
Fortune : 167 299 $ au 31/03/2024
Profil
Daniel G.
Billen's current job is Chairman at Aurinia Pharmaceuticals, Inc. His former jobs include Vice President & General Manager at Amgen, Inc., General Manager at Amgen Canada, Inc., and Head-Marketing & Sales at Janssen, Inc. He holds a doctorate degree from Université Catholique de Louvain.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/05/2023 | 33 393 ( 0,02% ) | 167 299 $ | 31/03/2024 |
Postes actifs de Daniel Billen
| Sociétés | Poste | Début |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Chairman | 18/08/2023 |
Anciens postes connus de Daniel Billen
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/01/2018 |
Amgen Canada, Inc.
 Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 01/01/2011 |
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Sales & Marketing | 01/01/1991 |
Formation de Daniel Billen
| Université Catholique de Louvain | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Amgen Canada, Inc.
Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Health Technology |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
